CIK 0001936258
- Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- Operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- Open-market buys, last 90 days
- $226,500
- in 1 filing
- Open-market sales, last 90 days
- $4,661,919
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,435,419. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-07 | Gulfo Adele M. Director | Grant or award | +3,400 | 14,260 | ||
| 2026-01-07 | Gulfo Adele M. Director | Grant or award · Option (right to buy) | +15,300 | 15,300 | ||
| 2025-04-15 | Gulfo Adele M. Director | Grant or award | +10,860 | 10,860 | ||
| 2025-04-15 | Gulfo Adele M. Director | Grant or award · Option (right to buy) | +50,700 | 50,700 |
Page 1 of 1 · 4 trades